147 related articles for article (PubMed ID: 29635808)
1. Cancer drug shortages: Awareness and perspectives from a representative sample of the US population.
Frosch ZAK; Cronin AM; Gagne JJ; Teschke MP; Gray SW; Abel GA
Cancer; 2018 May; 124(10):2205-2211. PubMed ID: 29635808
[TBL] [Abstract][Full Text] [Related]
2. A Qualitative Analysis of Oncology Patient Awareness of Medication Shortages and Their Preferences for How Shortages Should Be Managed.
Hantel A; Hlubocky FJ; Siegler M; Daugherty CK
JCO Oncol Pract; 2020 Oct; 16(10):e1098-e1111. PubMed ID: 32469685
[TBL] [Abstract][Full Text] [Related]
3. Exploring the opinions and experiences of patients with generic substitution: a representative study of Polish society.
Drozdowska A; Hermanowski T
Int J Clin Pharm; 2015 Feb; 37(1):68-75. PubMed ID: 25428446
[TBL] [Abstract][Full Text] [Related]
4. Framework for tackling paediatric chemotherapy drug shortages.
Tanday S
Lancet Oncol; 2016 Mar; 17(3):e93. PubMed ID: 26831287
[No Abstract] [Full Text] [Related]
5. Drug shortages delay cancer clinical trials.
Goozner M
J Natl Cancer Inst; 2012 Jun; 104(12):891-2. PubMed ID: 22715189
[No Abstract] [Full Text] [Related]
6. Impact of shortages of injectable oncology drugs on patient care.
Goldsack JC; Reilly C; Bush C; McElligott S; Bristol MN; Motanya UN; Field R; Vozniak JM; Wong YN; Schwartz JS; Domchek S
Am J Health Syst Pharm; 2014 Apr; 71(7):571-8. PubMed ID: 24644117
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy drug shortages in paediatric oncology: A 14-year single-centre experience in Belgium.
Bauters T; Claus BO; Norga K; Huys I; Simoens S; Laureys G
J Oncol Pharm Pract; 2016 Dec; 22(6):766-770. PubMed ID: 26447099
[TBL] [Abstract][Full Text] [Related]
8. Exploring factors underlying the attitude of community pharmacists to generic substitution: a nationwide study from Poland.
Drozdowska A; Hermanowski T
Int J Clin Pharm; 2016 Feb; 38(1):162-70. PubMed ID: 26620450
[TBL] [Abstract][Full Text] [Related]
9. Impact of oncology drug shortages on patient therapy: unplanned treatment changes.
Becker DJ; Talwar S; Levy BP; Thorn M; Roitman J; Blum RH; Harrison LB; Grossbard ML
J Oncol Pract; 2013 Jul; 9(4):e122-8. PubMed ID: 23942928
[TBL] [Abstract][Full Text] [Related]
10. National survey on the effect of oncology drug shortages on cancer care.
McBride A; Holle LM; Westendorf C; Sidebottom M; Griffith N; Muller RJ; Hoffman JM
Am J Health Syst Pharm; 2013 Apr; 70(7):609-17. PubMed ID: 23515514
[TBL] [Abstract][Full Text] [Related]
11. Religious hospital policies on reproductive care: what do patients want to know?
Freedman LR; Hebert LE; Battistelli MF; Stulberg DB
Am J Obstet Gynecol; 2018 Feb; 218(2):251.e1-251.e9. PubMed ID: 29221943
[TBL] [Abstract][Full Text] [Related]
12. The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology Group.
G Salazar E; Bernhardt MB; Li Y; Aplenc R; Adamson PC
Pediatr Blood Cancer; 2015 Jun; 62(6):940-4. PubMed ID: 25704486
[TBL] [Abstract][Full Text] [Related]
13. The impact of drug shortages on children with cancer--the example of mechlorethamine.
Metzger ML; Billett A; Link MP
N Engl J Med; 2012 Dec; 367(26):2461-3. PubMed ID: 23268661
[No Abstract] [Full Text] [Related]
14. Chemotherapy and Supportive Care Agents as Essential Medicines for Children With Cancer.
Unguru Y; Bernhardt MB; Berg SL; Johnson LM; Pyke-Grimm K; Woodman C; Fernandez CV
JAMA Pediatr; 2019 May; 173(5):477-484. PubMed ID: 30830204
[TBL] [Abstract][Full Text] [Related]
15. Drug shortages: Implications for medical toxicology.
Mazer-Amirshahi M; Hawley KL; Zocchi M; Fox E; Pines JM; Nelson LS
Clin Toxicol (Phila); 2015 Jul; 53(6):519-24. PubMed ID: 25951876
[TBL] [Abstract][Full Text] [Related]
16. Generic medications for you, but brand-name medications for me.
Keenum AJ; Devoe JE; Chisolm DJ; Wallace LS
Res Social Adm Pharm; 2012; 8(6):574-8. PubMed ID: 22357268
[TBL] [Abstract][Full Text] [Related]
17. Patients perspectives on drug shortages in six European hospital settings - a cross sectional study.
Kuruc Poje D; Kifer D; Huys I; Miranda J; Jenzer H; Miljković N; Hoppe-Tichy T; Bochniarz M; Frontini R; Schwartz DG; Vujić-Aleksić V; Nežić L; Rinaki E; Tzimis L; Green K; Jovanić J; Carić B; Mandić D; Vilić K; Bochenek T; Bačić Vrca V; Marušić S
BMC Health Serv Res; 2021 Jul; 21(1):689. PubMed ID: 34253212
[TBL] [Abstract][Full Text] [Related]
18. Critical drug shortages: implications for emergency medicine.
Mazer-Amirshahi M; Pourmand A; Singer S; Pines JM; van den Anker J
Acad Emerg Med; 2014 Jun; 21(6):704-11. PubMed ID: 25039558
[TBL] [Abstract][Full Text] [Related]
19. Ethical considerations for the clinical oncologist in an era of oncology drug shortages.
Jagsi R; Spence R; Rathmell WK; Bradbury A; Peppercorn J; Grubbs S; Moy B
Oncologist; 2014 Feb; 19(2):186-92. PubMed ID: 24449096
[TBL] [Abstract][Full Text] [Related]
20. Patient and public attitudes towards informed consent models and levels of awareness of Electronic Health Records in the UK.
Riordan F; Papoutsi C; Reed JE; Marston C; Bell D; Majeed A
Int J Med Inform; 2015 Apr; 84(4):237-47. PubMed ID: 25649841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
